Brokers Set Expectations for Humana Inc.’s Q1 2025 Earnings (NYSE:HUM)

Humana Inc. (NYSE:HUMFree Report) – Zacks Research increased their Q1 2025 EPS estimates for Humana in a research note issued to investors on Monday, June 3rd. Zacks Research analyst D. Chatterjee now expects that the insurance provider will post earnings of $6.53 per share for the quarter, up from their previous forecast of $6.52. The consensus estimate for Humana’s current full-year earnings is $16.00 per share. Zacks Research also issued estimates for Humana’s Q2 2025 earnings at $5.04 EPS and Q4 2025 earnings at $2.23 EPS.

A number of other analysts also recently issued reports on HUM. Barclays lowered their price objective on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 2nd. Royal Bank of Canada lowered their price objective on shares of Humana from $415.00 to $353.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Cantor Fitzgerald lowered their price objective on shares of Humana from $391.00 to $360.00 and set a “neutral” rating on the stock in a report on Thursday, April 25th. Robert W. Baird began coverage on shares of Humana in a report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price objective on the stock. Finally, Bank of America raised their target price on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a research note on Monday, May 20th. Thirteen equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $423.63.

View Our Latest Stock Report on HUM

Humana Price Performance

NYSE HUM opened at $360.87 on Wednesday. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. Humana has a 12-month low of $298.61 and a 12-month high of $530.54. The company has a market capitalization of $43.48 billion, a PE ratio of 22.47, a price-to-earnings-growth ratio of 2.14 and a beta of 0.53. The firm’s 50 day moving average is $330.26 and its 200-day moving average is $365.13.

Humana (NYSE:HUMGet Free Report) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $9.38 earnings per share.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Rakuten Securities Inc. acquired a new position in Humana in the fourth quarter valued at about $25,000. Gradient Investments LLC raised its stake in Humana by 200.0% in the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares in the last quarter. Cetera Trust Company N.A acquired a new position in Humana in the fourth quarter valued at about $28,000. Private Wealth Management Group LLC acquired a new position in Humana in the fourth quarter valued at about $32,000. Finally, Carolinas Wealth Consulting LLC raised its stake in Humana by 274.1% in the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after purchasing an additional 74 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Company Profile

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.